Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or pre...